Dementia Care and Brain Degenerative Diseases Grant
Funding Amount
Varies
Deadline
Rolling / Open
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Required status
- 501(c)(3) tax-exempt status
- In operation at least two years
- Must be a nonprofit with a 501(c)3 tax-exempt status or have a fiscal sponsor that has a 501(c)3 tax-exempt status.
Other requirements
- To be considered for funding, organizations must meet the following eligibility requirements:
Not eligible / not funded
- Not eligible: Please note that The Sephardic Foundation on Aging does not support:
- Not eligible: IndividualsEndowmentsColleges/Universities.
- Not eligible: Political Organizations/Action Groups.
- Not eligible: Debt reductionMulti-year grant proposals
Overview
The Dementia Care and Brain Degenerative Diseases Grant, offered by the Sephardic Home For The Aged Foundation, aims to support innovative projects enhancing care and quality of life for older adults affected by dementia. Eligible organizations must be 501(c)3 nonprofits in operation for at least two years. The Foundation prioritizes proposals focusing on dementia care, promoting collaboration and resource access for aging individuals. Interested applicants should submit a Letter of Inquiry through the online application system.
Note: All prospective grantees should first submit a Letter of Inquiry (LOI) through the online application system by the deadline above. Select LOI applicants will then be invited to submit a full grant application.
Priority Areas: End of Life Care or Preventing Elder Neglect; Dementia Care and Brain Degenerative Diseases; Combating Social Isolation of Older Adults
If your organization is working to support older adults in one or more of our priority areas, we would love to hear from you.
Projects typically focus on advancing care, support, and quality of life for people affected by dementia and related diseases, and the Foundation encourages innovative aging-related programs.re.
Eligibility
To be considered for funding, organizations must meet the following eligibility requirements: Must be a nonprofit with a 501(c)3 tax-exempt status or have a fiscal sponsor that has a 501(c)3 tax-exempt statusMust be in operation for at least two yearsIneligibility
Please note that The Sephardic Foundation on Aging does not support: IndividualsEndowmentsColleges/UniversitiesPolitical Organizations/Action GroupsDebt reductionMulti-year grant proposalsWhat Sephardic Home for the Aged Foundation actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 61
- Total given
- $3.41M
- Median grant
- $25K
- Range
- $2,000–$513K
- By dollars: New York 61%, New Jersey 15%, Colorado 6%. Top recipient cities: New York, NY; Rockville, MD; Brooklyn, NY.
- 52% of recipients were new grantees, not repeat recipients.
Example grants
Pef Israel Endowment Funds · New York, NY
$513K
Jewish Agency for Israel - North American Council · New York, NY
$345K
Struggle to Save Ethiopian Jewry · New York, NY
$300K
American Friends of Turkish Jewry · Tenafly, NJ
$255K
FJC · New York, NY
$195K
Focus Areas & Funding Uses
Fields of Work
- Nonprofits
- Seniors
- Alzheimer's
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
End of Life Care or Preventing Elder Neglect Grant
Sephardic Home for the Aged Foundation
Amount
Varies
Deadline
Rolling / Open
Combating Social Isolation of Older Adults Grant
Sephardic Home for the Aged Foundation
Amount
Varies
Deadline
Rolling / Open
Dementia Care and Caregiver Support Intervention Research - Stages II - V
National Institutes of Health
Amount
Varies
Deadline
Rolling / Open
Milton & Phyllis Berg Family Respite Care Grants
Alzheimer's Foundation of America Inc
Amount
US $6,000
Deadline
Rolling / Open
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 10, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
Ready to apply for Dementia Care and Brain Degenerative Diseases Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Dementia Care and Brain Degenerative Diseases Grant. Now let's win it.